B-Days hasta 60% OFF en Stock Limitado  Ver más

Enviar a
Quito, Pichincha
0
  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional

Selecciona tu país

América

Europa

Resto del mundo

Aprovecha esta PREVENTA
portada Aging and the Ethics of Longevity Science (en Inglés)
Formato
Libro Físico
Editorial
Año
2026
Idioma
Inglés
N° páginas
352
Encuadernación
Tapa Dura
Dimensiones
21x14 cm
ISBN13
9780197830031

Aging and the Ethics of Longevity Science (en Inglés)

Colin Farrelly (Autor) · OUP USA · Tapa Dura

Aging and the Ethics of Longevity Science (en Inglés) - Colin Farrelly

Libro Nuevo Importado
Envío: 39 a 46 días háb.
$ 240.02$ 120.01
-50%
Costos de importación incluídos en el precio ✅
Libro Nuevo

Quedan 20 unidades

$ 120.01
Llega entre el 23 Oct y el 09 Nov a Quito, Pichincha. Seleccionar ubicación

Reseña del libro "Aging and the Ethics of Longevity Science (en Inglés)"

A century of advances in experimental science have revealed new insights into the biology of aging, thus making the aspiration of healthy longevity a feasible goal for public health and medicine in the twenty-first century. However, significant obstacles must be overcome to reap the societal benefits of the science of healthy aging. These include t

A century of experimental science has revealed that the rate of biological aging is malleable, influenced by genetic, environmental, lifestyle, and pharmacological factors. Translational gerontology is now rapidly progressing from the bench to the clinic, ushering in a new ideal for longevity science--what the gerontologist Alex Comfort (1969) first coined "rate control." Unlike the medical paradigm of "disease control," which has increased survival time by suppressing causes of premature death, rate control aspires to increase healthspan and compress morbidity in late life by slowing the rate of aging through non-pharmacological (e.g. healthy environments, lifestyle) and potential pharmacological (e.g. geroprotective drugs) interventions.

Aging and the Ethics of Longevity Science examines the ethical and societal implications of population aging and longevity science. Should aging be construed as a disease? Will the development of aging drugs exacerbate or help redress health disparities? Should the development of such drugs be construed as something harmful or beneficial to planetary health? And how might rate control impact the health and wellbeing of women, who survive longer than men but with poorer health?

Dispensing with frames that perpetuate what he calls the "Frankensteinification" of translational gerontology, philosopher Colin Farrelly encourages instead an understanding of the societal significance of longevity science that is predicated upon "wisdom-inquiry" science (Maxwell 2007) and "responsible biology" (Kitcher 2004). A growing global healthspan-lifespan gap, the persistence of health disparities that arise from variations in unequal environmental exposures, the prevalence of ageism, and the politicalization of science present significant obstacles to the realization of healthy longevity. Farrelly advances a pragmatic ethical analysis that takes these predicaments seriously, encouraging the pursuit of wisdom-inquiry longevity science that is tempered to accommodate concern for living a good life and having a good death.

Opiniones del libro

Preguntas frecuentes sobre el libro

Todos los libros de nuestro catálogo son Originales.
El libro está escrito en Inglés.
La encuadernación de esta edición es Tapa Dura.

Preguntas y respuestas sobre el libro

¿Tienes una pregunta sobre el libro? Inicia sesión para poder agregar tu propia pregunta.

Opiniones sobre Buscalibre

Ver más opiniones de clientes